Open Access Highly Accessed Pre-publication history

Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte Oncology Network

Maria P Brizzi, Alfredo Berruti, Anna Ferrero, Enrica Milanesi, Marco Volante, Federico Castiglione, Nadia Birocco, Sebastiano Bombaci, Davide Perroni, Benedetta Ferretti, Oscar Alabiso, Libero Ciuffreda, Oscar Bertetto, Mauro Papotti and Luigi Dogliotti*

BMC Cancer 2009, 9:388  doi:10.1186/1471-2407-9-388

Pre-publication versions of this article and reviewers' reports

Original Submission - Version 1 Manuscript 16 Dec 2008
Reviewer's Report A Frilling 12 Feb 2009
Reviewer's Report Ralf-Dieter Hofheinz 15 Mar 2009
Reviewer's Report Aristides Polyzos 26 Mar 2009
Resubmission - Version 2 Manuscript Author's comment 17 Jun 2009
Resubmission - Version 3 Manuscript Author's comment 06 Aug 2009
Editorial acceptance 17 Aug 2009
Published 03 Nov 2009